PARTIAL IMPROVEMENT IN NEGATIVE SCHIZOPHRENIC SYMPTOMS AFTER AMPHETAMINE

被引:96
作者
ANGRIST, B [1 ]
PESELOW, E [1 ]
RUBINSTEIN, M [1 ]
CORWIN, J [1 ]
ROTROSEN, J [1 ]
机构
[1] NYU MED CTR,DEPT PSYCHIAT,NEW YORK,NY 10016
关键词
D O I
10.1007/BF00432248
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:128 / 130
页数:3
相关论文
共 18 条
[1]   BEHAVIORAL EFFECTS OF L-DOPA IN SCHIZOPHRENIC PATIENTS [J].
ANGRIST, B ;
SATHANANTHAN, G ;
GERSHON, S .
PSYCHOPHARMACOLOGIA, 1973, 31 (01) :1-12
[2]   DIFFERENTIAL-EFFECTS OF AMPHETAMINE AND NEUROLEPTICS ON NEGATIVE VS POSITIVE SYMPTOMS IN SCHIZOPHRENIA [J].
ANGRIST, B ;
ROTROSEN, J ;
GERSHON, S .
PSYCHOPHARMACOLOGY, 1980, 72 (01) :17-19
[3]   RESPONSES TO APOMORPHINE, AMPHETAMINE, AND NEUROLEPTICS IN SCHIZOPHRENIC SUBJECTS [J].
ANGRIST, B ;
ROTROSEN, J ;
GERSHON, S .
PSYCHOPHARMACOLOGY, 1980, 67 (01) :31-38
[4]  
ANGRIST BRJ, 1981, APOMORPHINE OTHER DO, V2, P33
[5]  
BOWERS MB, 1974, ARCH GEN PSYCHIAT, V31, P50
[6]   MOLECULAR PATHOLOGY OF SCHIZOPHRENIA - MORE THAN ONE DISEASE PROCESS [J].
CROW, TJ .
BRITISH MEDICAL JOURNAL, 1980, 280 (6207) :66-68
[7]  
Economo Constantin, 1931, ENCEPHALITIS LETHARG
[8]   EFFECT OF L-DOPA ON YOUNG PATIENTS WITH SIMPLE SCHIZOPHRENIA, TREATED WITH NEUROLEPTIC DRUGS - DOUBLE-BLIND CROSSOVER TRIAL WITH MADOPAR AND PLACEBO [J].
GERLACH, J ;
LUHDORF, K .
PSYCHOPHARMACOLOGIA, 1975, 44 (01) :105-110
[9]  
GUY W, 1976, ECDEU ASSESSMENT MAN, P160
[10]  
Hope JM, 1951, DIS NERV SYST, V12, P67